Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 27 | 2023 | 312 | 3.780 |
Why?
|
Positron-Emission Tomography | 25 | 2020 | 172 | 2.850 |
Why?
|
tau Proteins | 14 | 2019 | 38 | 2.770 |
Why?
|
Brain | 19 | 2020 | 930 | 2.350 |
Why?
|
Aging | 13 | 2018 | 881 | 2.130 |
Why?
|
Magnetic Resonance Imaging | 23 | 2023 | 1218 | 1.290 |
Why?
|
Cerebral Cortex | 9 | 2020 | 141 | 1.220 |
Why?
|
Carbolines | 7 | 2018 | 9 | 1.180 |
Why?
|
Cognition | 5 | 2019 | 526 | 1.040 |
Why?
|
Temporal Lobe | 4 | 2017 | 41 | 0.910 |
Why?
|
Aged | 41 | 2022 | 9487 | 0.810 |
Why?
|
Fluorine Radioisotopes | 2 | 2020 | 21 | 0.750 |
Why?
|
Aged, 80 and over | 24 | 2020 | 3717 | 0.750 |
Why?
|
Aniline Compounds | 9 | 2020 | 25 | 0.750 |
Why?
|
Diffusion Tensor Imaging | 4 | 2016 | 29 | 0.700 |
Why?
|
Amyloid | 5 | 2019 | 17 | 0.680 |
Why?
|
Frontal Lobe | 2 | 2016 | 45 | 0.660 |
Why?
|
Male | 42 | 2023 | 17807 | 0.650 |
Why?
|
Humans | 51 | 2023 | 29093 | 0.630 |
Why?
|
Female | 41 | 2023 | 18164 | 0.630 |
Why?
|
Aminopyridines | 1 | 2016 | 7 | 0.580 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2013 | 31 | 0.580 |
Why?
|
Quinolines | 1 | 2016 | 27 | 0.570 |
Why?
|
Task Performance and Analysis | 1 | 2015 | 51 | 0.520 |
Why?
|
Neuropsychological Tests | 10 | 2020 | 379 | 0.510 |
Why?
|
Nerve Net | 1 | 2015 | 115 | 0.470 |
Why?
|
Attention | 1 | 2013 | 83 | 0.450 |
Why?
|
Disease Progression | 7 | 2019 | 572 | 0.450 |
Why?
|
Thiazoles | 5 | 2018 | 32 | 0.430 |
Why?
|
Stilbenes | 3 | 2020 | 25 | 0.400 |
Why?
|
Dementia | 4 | 2018 | 234 | 0.380 |
Why?
|
Sex Characteristics | 3 | 2020 | 167 | 0.350 |
Why?
|
Cognition Disorders | 2 | 2016 | 390 | 0.350 |
Why?
|
Middle Aged | 23 | 2022 | 10829 | 0.350 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2018 | 113 | 0.320 |
Why?
|
Fluorodeoxyglucose F18 | 5 | 2018 | 56 | 0.300 |
Why?
|
Apolipoproteins E | 5 | 2018 | 97 | 0.290 |
Why?
|
Glucose | 2 | 2019 | 163 | 0.290 |
Why?
|
Benzothiazoles | 3 | 2020 | 4 | 0.270 |
Why?
|
Brain Mapping | 2 | 2016 | 182 | 0.260 |
Why?
|
Cues | 2 | 2015 | 67 | 0.240 |
Why?
|
Arteries | 1 | 2023 | 60 | 0.230 |
Why?
|
Young Adult | 5 | 2017 | 2402 | 0.220 |
Why?
|
Case-Control Studies | 4 | 2018 | 859 | 0.220 |
Why?
|
Radiopharmaceuticals | 3 | 2018 | 87 | 0.220 |
Why?
|
Amnesia | 2 | 2019 | 10 | 0.210 |
Why?
|
Adult | 9 | 2020 | 8420 | 0.210 |
Why?
|
Executive Function | 2 | 2019 | 54 | 0.200 |
Why?
|
Memory Disorders | 2 | 2018 | 61 | 0.190 |
Why?
|
Memory | 2 | 2019 | 187 | 0.190 |
Why?
|
Aphasia, Broca | 1 | 2019 | 1 | 0.180 |
Why?
|
Cerebrovascular Circulation | 4 | 2023 | 95 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 1379 | 0.180 |
Why?
|
Vital Capacity | 1 | 2019 | 44 | 0.180 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 19 | 0.180 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 112 | 0.180 |
Why?
|
Insulin | 1 | 2022 | 346 | 0.180 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 23 | 0.180 |
Why?
|
Corpus Striatum | 1 | 2020 | 60 | 0.180 |
Why?
|
Frontotemporal Dementia | 1 | 2019 | 7 | 0.170 |
Why?
|
Neural Pathways | 3 | 2017 | 97 | 0.170 |
Why?
|
Models, Biological | 2 | 2018 | 373 | 0.170 |
Why?
|
Radionuclide Imaging | 1 | 2018 | 23 | 0.170 |
Why?
|
Autopsy | 1 | 2018 | 37 | 0.170 |
Why?
|
Language Disorders | 1 | 2018 | 3 | 0.170 |
Why?
|
Vascular Diseases | 1 | 2019 | 61 | 0.160 |
Why?
|
Inflammation | 1 | 2022 | 507 | 0.160 |
Why?
|
Entorhinal Cortex | 1 | 2017 | 2 | 0.160 |
Why?
|
Overweight | 1 | 2020 | 256 | 0.160 |
Why?
|
Nerve Degeneration | 1 | 2017 | 10 | 0.160 |
Why?
|
Nomograms | 1 | 2018 | 30 | 0.160 |
Why?
|
Follow-Up Studies | 6 | 2019 | 2108 | 0.160 |
Why?
|
Neocortex | 1 | 2017 | 5 | 0.150 |
Why?
|
Neurodegenerative Diseases | 1 | 2017 | 13 | 0.150 |
Why?
|
Carbon Radioisotopes | 1 | 2017 | 20 | 0.150 |
Why?
|
Time Factors | 3 | 2019 | 2001 | 0.150 |
Why?
|
Severity of Illness Index | 2 | 2017 | 863 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2019 | 422 | 0.140 |
Why?
|
Attitude to Health | 1 | 2017 | 148 | 0.140 |
Why?
|
Obesity | 2 | 2020 | 1063 | 0.140 |
Why?
|
Models, Theoretical | 1 | 2017 | 126 | 0.140 |
Why?
|
Reproducibility of Results | 4 | 2023 | 726 | 0.140 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 48 | 0.130 |
Why?
|
Stress, Psychological | 1 | 2017 | 208 | 0.130 |
Why?
|
Behavior | 1 | 2015 | 29 | 0.130 |
Why?
|
Demography | 1 | 2015 | 104 | 0.130 |
Why?
|
Cohort Studies | 4 | 2022 | 1687 | 0.130 |
Why?
|
Cluster Analysis | 1 | 2015 | 128 | 0.130 |
Why?
|
Risk Assessment | 2 | 2018 | 1305 | 0.130 |
Why?
|
Atrophy | 3 | 2019 | 51 | 0.130 |
Why?
|
Reaction Time | 1 | 2013 | 121 | 0.110 |
Why?
|
Blood Pressure | 1 | 2017 | 804 | 0.110 |
Why?
|
Photic Stimulation | 1 | 2013 | 155 | 0.110 |
Why?
|
Analysis of Variance | 1 | 2013 | 454 | 0.110 |
Why?
|
Anisotropy | 1 | 2012 | 10 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 1013 | 0.100 |
Why?
|
Risk Factors | 4 | 2020 | 3531 | 0.100 |
Why?
|
Adolescent | 2 | 2017 | 3254 | 0.090 |
Why?
|
Prognosis | 3 | 2018 | 1362 | 0.090 |
Why?
|
Multiple Sclerosis | 1 | 2009 | 43 | 0.080 |
Why?
|
Neurons | 1 | 2012 | 394 | 0.080 |
Why?
|
Pilot Projects | 2 | 2020 | 469 | 0.080 |
Why?
|
Ethylene Glycols | 2 | 2017 | 8 | 0.070 |
Why?
|
Reference Values | 2 | 2018 | 224 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 242 | 0.070 |
Why?
|
Computer Simulation | 2 | 2018 | 207 | 0.070 |
Why?
|
Hippocampus | 2 | 2018 | 185 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2018 | 720 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 1356 | 0.070 |
Why?
|
Quality of Life | 1 | 2009 | 816 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 50 | 0.060 |
Why?
|
Spin Labels | 1 | 2023 | 23 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 91 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2022 | 30 | 0.050 |
Why?
|
Ketone Bodies | 1 | 2019 | 6 | 0.050 |
Why?
|
Isoenzymes | 1 | 2020 | 63 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2020 | 165 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2019 | 94 | 0.040 |
Why?
|
United States | 2 | 2019 | 3630 | 0.040 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2019 | 7 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2018 | 7 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 42 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2018 | 18 | 0.040 |
Why?
|
Language | 1 | 2019 | 44 | 0.040 |
Why?
|
Risk | 1 | 2019 | 289 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 871 | 0.040 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 46 | 0.040 |
Why?
|
Contrast Media | 1 | 2018 | 123 | 0.040 |
Why?
|
Tauopathies | 1 | 2017 | 5 | 0.040 |
Why?
|
Neurofibrillary Tangles | 1 | 2017 | 7 | 0.040 |
Why?
|
Dementia, Vascular | 1 | 2017 | 13 | 0.040 |
Why?
|
Brain Stem | 1 | 2017 | 18 | 0.040 |
Why?
|
Cerebellum | 1 | 2017 | 29 | 0.040 |
Why?
|
Parietal Lobe | 1 | 2017 | 16 | 0.040 |
Why?
|
Organ Size | 1 | 2018 | 196 | 0.040 |
Why?
|
Age of Onset | 1 | 2017 | 95 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 787 | 0.040 |
Why?
|
Models, Neurological | 1 | 2018 | 115 | 0.040 |
Why?
|
Protein Interaction Mapping | 1 | 2016 | 8 | 0.040 |
Why?
|
Metabolic Clearance Rate | 1 | 2016 | 17 | 0.040 |
Why?
|
Molecular Imaging | 1 | 2016 | 22 | 0.040 |
Why?
|
Image Enhancement | 1 | 2016 | 70 | 0.040 |
Why?
|
Kinetics | 1 | 2016 | 205 | 0.040 |
Why?
|
Body Mass Index | 1 | 2019 | 865 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 92 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 53 | 0.030 |
Why?
|
Registries | 1 | 2017 | 278 | 0.030 |
Why?
|
Algorithms | 1 | 2018 | 462 | 0.030 |
Why?
|
Radiography | 1 | 2014 | 353 | 0.030 |
Why?
|
Age Factors | 1 | 2016 | 1108 | 0.030 |
Why?
|
Prospective Studies | 1 | 2018 | 2019 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2018 | 3111 | 0.020 |
Why?
|
Psychometrics | 1 | 2009 | 129 | 0.020 |
Why?
|